vs

Side-by-side financial comparison of Hims & Hers Health, Inc. (HIMS) and Verisign (VRSN). Click either name above to swap in a different company.

Hims & Hers Health, Inc. is the larger business by last-quarter revenue ($617.8M vs $425.3M, roughly 1.5× Verisign). Verisign runs the higher net margin — 48.5% vs 3.3%, a 45.1% gap on every dollar of revenue. On growth, Hims & Hers Health, Inc. posted the faster year-over-year revenue change (28.4% vs 7.6%). Verisign produced more free cash flow last quarter ($285.1M vs $-2.5M). Over the past eight quarters, Hims & Hers Health, Inc.'s revenue compounded faster (49.0% CAGR vs 5.2%).

Hims & Hers Health, Inc. is an American telehealth company established in 2017. The company provides prescription medications, over-the-counter medications, and personal care products.

Verisign, Inc. is an American company based in Reston, Virginia, that operates a diverse array of network infrastructure, including two of the Internet's thirteen root nameservers, the authoritative registry for the .com, .net, and .name generic top-level domains and the .cc country-code top-level domains, and the back-end systems for the .jobs and .edu sponsored top-level domains.

HIMS vs VRSN — Head-to-Head

Bigger by revenue
HIMS
HIMS
1.5× larger
HIMS
$617.8M
$425.3M
VRSN
Growing faster (revenue YoY)
HIMS
HIMS
+20.8% gap
HIMS
28.4%
7.6%
VRSN
Higher net margin
VRSN
VRSN
45.1% more per $
VRSN
48.5%
3.3%
HIMS
More free cash flow
VRSN
VRSN
$287.6M more FCF
VRSN
$285.1M
$-2.5M
HIMS
Faster 2-yr revenue CAGR
HIMS
HIMS
Annualised
HIMS
49.0%
5.2%
VRSN

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
HIMS
HIMS
VRSN
VRSN
Revenue
$617.8M
$425.3M
Net Profit
$20.6M
$206.2M
Gross Margin
71.9%
88.5%
Operating Margin
1.5%
67.0%
Net Margin
3.3%
48.5%
Revenue YoY
28.4%
7.6%
Net Profit YoY
-20.8%
7.7%
EPS (diluted)
$0.08

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HIMS
HIMS
VRSN
VRSN
Q4 25
$617.8M
$425.3M
Q3 25
$599.0M
$419.1M
Q2 25
$544.8M
$409.9M
Q1 25
$586.0M
$402.3M
Q4 24
$481.1M
$395.4M
Q3 24
$401.6M
$390.6M
Q2 24
$315.6M
$387.1M
Q1 24
$278.2M
$384.3M
Net Profit
HIMS
HIMS
VRSN
VRSN
Q4 25
$20.6M
$206.2M
Q3 25
$15.8M
$212.8M
Q2 25
$42.5M
$207.4M
Q1 25
$49.5M
$199.3M
Q4 24
$26.0M
$191.5M
Q3 24
$75.6M
$201.3M
Q2 24
$13.3M
$198.8M
Q1 24
$11.1M
$194.1M
Gross Margin
HIMS
HIMS
VRSN
VRSN
Q4 25
71.9%
88.5%
Q3 25
73.8%
88.4%
Q2 25
76.4%
88.0%
Q1 25
73.5%
87.7%
Q4 24
76.8%
87.8%
Q3 24
79.2%
88.0%
Q2 24
81.3%
87.8%
Q1 24
82.4%
87.2%
Operating Margin
HIMS
HIMS
VRSN
VRSN
Q4 25
1.5%
67.0%
Q3 25
2.0%
67.8%
Q2 25
4.9%
68.5%
Q1 25
9.9%
67.4%
Q4 24
3.9%
66.7%
Q3 24
5.6%
68.9%
Q2 24
3.5%
68.8%
Q1 24
3.6%
67.4%
Net Margin
HIMS
HIMS
VRSN
VRSN
Q4 25
3.3%
48.5%
Q3 25
2.6%
50.8%
Q2 25
7.8%
50.6%
Q1 25
8.4%
49.5%
Q4 24
5.4%
48.4%
Q3 24
18.8%
51.5%
Q2 24
4.2%
51.4%
Q1 24
4.0%
50.5%
EPS (diluted)
HIMS
HIMS
VRSN
VRSN
Q4 25
$0.08
Q3 25
$0.06
Q2 25
$0.17
Q1 25
$0.20
Q4 24
$0.10
Q3 24
$0.32
Q2 24
$0.06
Q1 24
$0.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HIMS
HIMS
VRSN
VRSN
Cash + ST InvestmentsLiquidity on hand
$228.6M
$580.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$540.9M
$-2.2B
Total Assets
$2.2B
$1.3B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HIMS
HIMS
VRSN
VRSN
Q4 25
$228.6M
$580.5M
Q3 25
$345.8M
$617.7M
Q2 25
$1.1B
$593.8M
Q1 25
$273.7M
$648.5M
Q4 24
$220.6M
$599.9M
Q3 24
$165.5M
$644.9M
Q2 24
$129.3M
$689.9M
Q1 24
$105.2M
$924.7M
Stockholders' Equity
HIMS
HIMS
VRSN
VRSN
Q4 25
$540.9M
$-2.2B
Q3 25
$581.0M
$-2.1B
Q2 25
$562.7M
$-2.0B
Q1 25
$549.3M
$-2.0B
Q4 24
$476.7M
$-2.0B
Q3 24
$440.1M
$-1.9B
Q2 24
$362.0M
$-1.8B
Q1 24
$344.5M
$-1.6B
Total Assets
HIMS
HIMS
VRSN
VRSN
Q4 25
$2.2B
$1.3B
Q3 25
$2.2B
$1.4B
Q2 25
$1.9B
$1.4B
Q1 25
$891.7M
$1.4B
Q4 24
$707.5M
$1.4B
Q3 24
$602.3M
$1.5B
Q2 24
$480.5M
$1.5B
Q1 24
$448.1M
$1.7B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HIMS
HIMS
VRSN
VRSN
Operating Cash FlowLast quarter
$61.3M
$289.6M
Free Cash FlowOCF − Capex
$-2.5M
$285.1M
FCF MarginFCF / Revenue
-0.4%
67.0%
Capex IntensityCapex / Revenue
10.3%
1.1%
Cash ConversionOCF / Net Profit
2.98×
1.40×
TTM Free Cash FlowTrailing 4 quarters
$57.4M
$1.1B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HIMS
HIMS
VRSN
VRSN
Q4 25
$61.3M
$289.6M
Q3 25
$148.7M
$307.7M
Q2 25
$-19.1M
$202.5M
Q1 25
$109.1M
$291.3M
Q4 24
$86.4M
$231.5M
Q3 24
$85.3M
$253.4M
Q2 24
$53.6M
$160.4M
Q1 24
$25.8M
$257.3M
Free Cash Flow
HIMS
HIMS
VRSN
VRSN
Q4 25
$-2.5M
$285.1M
Q3 25
$79.3M
$303.0M
Q2 25
$-69.5M
$194.7M
Q1 25
$50.1M
$285.5M
Q4 24
$59.5M
$222.0M
Q3 24
$79.4M
$247.8M
Q2 24
$47.6M
$151.2M
Q1 24
$11.8M
$253.5M
FCF Margin
HIMS
HIMS
VRSN
VRSN
Q4 25
-0.4%
67.0%
Q3 25
13.2%
72.3%
Q2 25
-12.8%
47.5%
Q1 25
8.5%
71.0%
Q4 24
12.4%
56.1%
Q3 24
19.8%
63.4%
Q2 24
15.1%
39.1%
Q1 24
4.3%
66.0%
Capex Intensity
HIMS
HIMS
VRSN
VRSN
Q4 25
10.3%
1.1%
Q3 25
11.6%
1.1%
Q2 25
9.3%
1.9%
Q1 25
10.1%
1.4%
Q4 24
5.6%
2.4%
Q3 24
1.5%
1.4%
Q2 24
1.9%
2.4%
Q1 24
5.0%
1.0%
Cash Conversion
HIMS
HIMS
VRSN
VRSN
Q4 25
2.98×
1.40×
Q3 25
9.43×
1.45×
Q2 25
-0.45×
0.98×
Q1 25
2.20×
1.46×
Q4 24
3.32×
1.21×
Q3 24
1.13×
1.26×
Q2 24
4.03×
0.81×
Q1 24
2.32×
1.33×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons